Preetam Shah
CIK 1787403 · See Remarks · last filed 2026-02-03
Preetam Shah is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ELTX, was dated Feb 3, 2026. Across all open-market trades the lifetime net is +$41.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $365.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$365.1K
3
14
$41.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELTX | See Remarks | 24,000 | $14.85 | $356.4K | $0 | 2 | 2026-02-03 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Financial Officer | 335,960 | $221.38 | $74.37M | -$4.1K | 9 | 2024-10-02 |
| BCLI | EVP, CFO and Treasurer | 11,600 | $0.75 | $8.7K | $45.9K | 3 | 2020-12-31 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | ELTX | Grant (A) | +24,000 | $0 | EDGAR |
| 2025-04-16 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2024-10-02 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-20 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | +108,750 | $0 | EDGAR |
| 2024-03-12 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −18,931 | -$12.7K | EDGAR |
| 2023-03-29 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | +90,000 | $0 | EDGAR |
| 2023-03-13 | Cidara Therapeutics, Inc. (CDTX) Delisted | Sell (S) | −6,648 | -$10.2K | EDGAR |
| 2022-09-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | +34,358 | -$12.0K | EDGAR |
| 2022-04-04 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | +92,431 | -$20.6K | EDGAR |
| 2021-11-15 | Cidara Therapeutics, Inc. (CDTX) Delisted | Buy (P) | +20,000 | $30.8K | EDGAR |